Mercy Medical Center, Inc.

Baltimore, Maryland 21202

0 studies enrolling now · 8 studies all time

What they study most

Chronic Hepatitis C, Fallopian Tube Cancer, Hepatitis C, Hepatocellular Carcinoma (HCC), Metastatic Cancer, Non-alcoholic Steatohepatitis (NASH), Ovarian Cancer, Primary Peritoneal Cavity Cancer

Studies at this site

• Hepatocellular Carcinoma Study Comparing Vaccinia Virus Based Immunotherapy Plus Sorafenib vs Sorafenib Alone — Completed
• Genetic Data Collection in Adult Participants to Identify Genetic Variants of Known Importance in Non-alcoholic Steatohepatitis (NASH) — Stopped early
• ILX-295501 in Treating Patients With Stage III or Stage IV Ovarian Cancer That Has Not Responded to Previous Treatment — Withdrawn before enrolling
• Study to Determine the Effectiveness and Safety of a Three Drug Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) Infected Patients Not Previously Treated With Currently Available Medications — Completed
• A Multicenter Treatment Protocol of Daclatasvir (BMS-790052) in Combination With Sofosbuvir for the Treatment of Post-Liver Transplant Subjects With Chronic Hepatitis C — NO_LONGER_AVAILABLE
• Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV — Completed
• Monoclonal Antibody Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer — Status unconfirmed
• Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube Cancer — Completed